Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,599 GBX | +0.98% | -2.71% | +10.26% |
Apr. 17 | GSK Reports Positive Data for Gonorrhea Treatment Gepotidacin, Shingles Vaccine Shingrix | MT |
Apr. 17 | GSK: positive clinical results for gonorrhea | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.26% | 80.65B | |
+24.80% | 672B | |
+24.08% | 550B | |
-5.83% | 351B | |
+15.56% | 317B | |
+7.22% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-9.80% | 144B | |
-6.62% | 141B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GlaxoSmithKline : Shingles Vaccine Gets Expanded US Nod For Immunocompromised Adults